FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Hermanns, MI; Kasper, J; Dubruel, P et al.
An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interactionJOURNAL OF THE ROYAL SOCIETY INTERFACE. Bd. 7. 2010 S. S41-S54
Spanagel, R; Bartsch, D; Brors, B et al.
An integrated genome research network for studying the genetics of alcohol addictionADDICTION BIOLOGY. Bd. 15. H. 4. 2010 S. 369-379
Andersen, JB; Factor, VM; Marquardt, JU et al.
An Integrated Genomic and Epigenomic Approach Predicts Therapeutic Response to Zebularine in Human Liver CancerSCIENCE TRANSLATIONAL MEDICINE. Bd. 2. H. 54. 2010 S. -
Schmidt, M; Scheulen, ME; Dittrich, C et al.
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancerANNALS OF ONCOLOGY. Bd. 21. H. 2. 2010 S. 275-282
Stumpf, M; Will, B; Wittig, K et al.
An organizing region in metamorphosing hydrozoan planula larvae - stimulation of axis formation in both larval and in adult tissueINTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. Bd. 54. H. 5. 2010 S. 795-802
Knauer, SK; Heinrich, UR; Bier, C et al.
An otoprotective role for the apoptosis inhibitor protein survivinCELL DEATH & DISEASE. Bd. 1. 2010 S. -
Stauber, RH; Wunsch, D; Knauer, SK et al.
An update on the pathobiological relevance of nuclear receptors for cancers of the head and neckHISTOLOGY AND HISTOPATHOLOGY. Bd. 25. H. 8. 2010 S. 1093-1104
Messow, Claudia-Martina
Analyse von Überlebenszeiten bei hochdimensionalen DatenMainz: Univ. 2010 209 S.
Muller, HL; Gebhardt, U; Schroder, S et al.
Analyses of Treatment Variables for Patients with Childhood Craniopharyngioma - Results of the Multicenter Prospective Trial KRANIOPHARYNGEOM 2000 after Three Years of Follow-UpHORMONE RESEARCH IN PAEDIATRICS. Bd. 73. H. 3. 2010 S. 175-180
Lyros, O; Mueller, A; Heidel, F et al.
Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathwaysINTERNATIONAL JOURNAL OF CANCER. Bd. 127. H. 5. 2010 S. 1197-1208